- Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program2016 | 3. lékařská fakulta
- Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain: 2-Year Results From the IN.PACT Global Study2018 | Publikace bez příslušnosti k fakultě
- Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-Year final clinical outcomes from the MASCOT post-marketing registry2019 | Publikace bez příslušnosti k fakultě
- Prognostický význam ischemií modifikovaného albuminu po perkutánní koronární intervenci2006 | Publikace bez příslušnosti k fakultě
- Prognostický význam ischemií modifikovaného albuminu po perkutánní koronární intervenci2006 | Lékařská fakulta v Hradci Králové
- Prognostický význam ischemií modifikovaného albuminu po perkutánní koronární intervenci +12006 | 1. lékařská fakulta
- Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal CohortPublikace bez příslušnosti k fakultě
- Prognostic significance of ischemia modified albumin after percutaneous coronary intervention2006 | Lékařská fakulta v Hradci Králové
- Angioplasty of Dysfunctional Dialysis Fistula or Graft with Resveratrol-Excipient and Paclitaxel-Coated Balloon Improves Primary Patency Rates Compared to Plain Angioplasty Alone2022 | 1. lékařská fakulta
- Clinical results with the Resolute zotarolimus-eluting stent in total coronary occlusions2015 | 3. lékařská fakulta
- Comparison of One-Year Outcomes in Patients >75 Versus <=75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry)2020 | Publikace bez příslušnosti k fakultě
- One-year outcomes of patients with the zotarolimus-eluting coronary stent: RESOLUTE International Registry2012 | 3. lékařská fakulta
- Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration2021 | Publikace bez příslušnosti k fakultě
- Long-term outcomes after Resolute zotarolimus-eluting stent implantation in patients with ST-segment elevation acute myocardial infarction: insights from the RESOLUTE All Corners Trial and the RESOLUTE Global Clinical Trial Program2016 | 3. lékařská fakulta
- Three-Year Outcomes of Percutaneous Coronary Intervention With Next-Generation Zotarolimus-Eluting Stents for De Novo Coronary Bifurcation Lesions2014 | 3. lékařská fakulta
- Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE- ABSORB randomised clinical trial2020 | 3. lékařská fakulta
- The influence of age on clinical outcomes in patients treated with the resolute zotarolimus-eluting stent2016 | 3. lékařská fakulta
- Clinical Outcome of Patients With and Without Diabetes Mellitus After Percutaneous Coronary Intervention With the Resolute Zotarolimus-Eluting Stent 2-Year Results From the Prospectively Pooled Analysis of the International Global RESOLUTE Program2013 | 3. lékařská fakulta
- Real-World Safety and Effectiveness Outcomes of a Zotarolimus-Eluting Stent: Final 3-Year Report of the RESOLUTE International Study2013 | 3. lékařská fakulta
- Impact of Body Mass Index on Long-Term Clinical Outcomes After Second-Generation Drug Eluting Stent Implantation: Insights From the International Global RESOLUTE Program2015 | 3. lékařská fakulta
- Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB Trial2019 | 3. lékařská fakulta
- 1-year results after PCI with the COMBO stent in all-comers in Asia versus Europe: Geographical insights from the COMBO collaboration2020 | Publikace bez příslušnosti k fakultě
- One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration2021 | Publikace bez příslušnosti k fakultě
- New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemia2018 | 2. lékařská fakulta
- Clinical Outcomes of the Resolute Zotarolimus-Eluting Stent in Patients With In-Stent Restenosis2013 | 3. lékařská fakulta
- 1-Year outcomes with COMBO stents in small vessel coronary disease: Subgroup analysis from the COMBO collaboration2020 | Publikace bez příslušnosti k fakultě
- 1-Year COMBO stent outcomes stratified by the PARIS bleeding prediction score: From the MASCOT registry2020 | Publikace bez příslušnosti k fakultě
- Resolute zotarolimus-eluting coronary stent system for the treatment of coronary artery disease2014 | 3. lékařská fakulta
- Performance of the Resolute Zotarolimus-Eluting Stent in Small Vessels2014 | 3. lékařská fakulta